MARKET

CARL

CARL

CARLSMED INC
NASDAQ
11.01
+0.25
+2.32%
After Hours: 11.31 +0.3 +2.72% 18:29 05/15 EDT
OPEN
10.47
PREV CLOSE
10.76
HIGH
11.20
LOW
10.47
VOLUME
323.30K
TURNOVER
--
52 WEEK HIGH
17.19
52 WEEK LOW
8.50
MARKET CAP
299.31M
P/E (TTM)
-2.5909
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CARL last week (0504-0508)?
Weekly Report · 5d ago
Carlsmed (CARL) Revenue Growth Of 74.9% Tests Bullish Narratives On Premium Valuation
Simply Wall St · 05/07 00:36
Piper Sandler Sticks to Its Buy Rating for Carlsmed, Inc. (CARL)
TipRanks · 05/06 11:59
Carlsmed, Inc. (CARL) Gets a Buy from Goldman Sachs
TipRanks · 05/06 11:37
Carlsmed Price Target Maintained With a $23.00/Share by BTIG
Dow Jones · 05/06 10:11
Zimmerman Reiterates Buy on Carlsmed After Strong Q1, Raises 2026 Outlook and Keeps $23 Price Target Unchanged
TipRanks · 05/06 09:55
Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for aprevo lumbar
Seeking Alpha · 05/06 03:02
Carlsmed Earnings Call Highlights Growth, Rising Costs
TipRanks · 05/06 01:20
More
About CARL
Carlsmed, Inc. is a commercial-stage medical technology company providing AI-enabled personalized spine surgery solutions. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights for each surgeon. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.

Webull offers Carlsmed, Inc. stock information, including NASDAQ: CARL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CARL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CARL stock methods without spending real money on the virtual paper trading platform.